Oral JAK Inhibitor for Alopecia Areata Advances to Phase 3 Oral JAK Inhibitor for Alopecia Areata Advances to Phase 3

"So far, I ' d say that the results are very encouraging from this study, as we see good safety and continued stability of the hair regrowth in the open-label extension," said Dr Cassella.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news